en · de · es · pt
epitalon-notes.peptides7501.com › Topic › Origin And Telomerase Research Claims — Reference Sheet

Origin And Telomerase Research Claims — Reference Sheet

By Editorial Desk · published 2025-10-29 · last reviewed 2025-11-12 · Topic

Everything below concerns epithalamin. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2025-11-12. Where a claim depends on a specific study, the study is described rather than over-claimed.

Origin and Telomerase Research Claims

Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.

Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.

Epitalon Peptide Background and Structure

Interest in epitalon is usually discussed within the broader field of short peptide bioregulators, a category that includes other synthetic di-, tri-, and tetrapeptides studied by the same research group. These compounds share a common rationale: that small fragments of tissue-derived proteins can retain biological activity and can be produced reproducibly. The category as a whole remains outside mainstream pharmacological consensus, and epitalon specifically has a limited presence in independent, non-Russian research literature, which shapes how its evidence base is described.

Epitalon is a synthetic tetrapeptide with the amino acid sequence alanine-glutamate-aspartate-glycine, abbreviated Ala-Glu-Asp-Gly or AEDG. It was developed by the Russian researcher Vladimir Khavinson and colleagues during work on peptide bioregulators derived from the pineal gland. The compound is short enough to be produced by standard solid-phase peptide synthesis and is typically handled as a lyophilized white powder. Its small size distinguishes it from larger pineal peptides such as epithalamin, a complex extract from which the tetrapeptide was conceptually derived.

Epitalon at a glance

PropertyValueNotes
Peptide sequenceAla-Glu-Asp-GlySingle-letter form AEDG
Compound classSynthetic tetrapeptideNot a natural free peptide
Research originRussian gerontology institutesDeveloped during the 1990s
Main research claimTelomerase activationEvidence mainly from cultured cells
Regulatory statusNot an approved drugHandled as a research material

Laboratory Handling and Analytical Verification

Short peptides such as AEDG are normally supplied as a freeze-dried solid and are kept dry, cold, and shielded from light. Holding at minus twenty degrees Celsius is common for the long term, while a refrigerator suffices for brief periods before use. The material takes up moisture to some degree, so containers should stay sealed and be allowed to reach room temperature before opening, which limits condensation on the contents. Repeated warming and cooling of a single container is discouraged because it admits water and can lower the amount of intact peptide.

Dissolution is usually performed in water or a suitable aqueous buffer, and the resulting liquid is divided into single-use portions before freezing. Freeze-thaw cycling is a recognised source of loss for short peptides, since each cycle can encourage aggregation or adsorption onto container walls. Working solutions are generally kept cold and used within a short window, although published stability data specific to epitalon are thin. Containers should be marked with concentration and date, and solutions examined for cloudiness before use.

Related pages on this site

Epitalon Background And Identification

Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.

The parent extract epithalamin was characterised as a low-molecular-weight fraction of pineal tissue rather than a single defined chemical entity. Researchers fractionated it and tested successive fragments for activity, a screening approach typical of peptide discovery work in that era. Epitalon emerged from that process as one of the shorter sequences of interest. Because the original extract was never fully resolved into individual components, claims about which constituent drives a given effect rest on inference. This distinction matters when reading older reports that attribute extract observations to the tetrapeptide itself.

Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.

Research Claims and Evidence Status

No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.

The most frequently cited laboratory finding is that AEDG increased telomerase activity and extended telomere length in cultured human somatic cells. That work used fetal fibroblast strains and reported changes in enzyme activity alongside altered division counts. Replication by unrelated groups has been limited, and the published record is largely a single-laboratory series rather than a multi-centre programme. The result supports a hypothesis about peptide influence on gene expression in cell culture; it does not by itself establish an effect on telomere length in living animals or in people.

Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.

Chemical Identity and Research Background

In its supplied form epitalon is a white to off-white powder, usually lyophilized and often hygroscopic. It dissolves readily in water and in aqueous buffers, and it is commonly handled as the acetate or trifluoroacetate salt to improve stability during purification and drying. The amide backbone is labile in aqueous media, so solutions are less durable than the dry solid. Handling notes in the chemical literature therefore emphasize keeping the powder dry, cool and shielded from light until it is dissolved.

Epitalon is a synthetic tetrapeptide whose sequence is alanine-glutamate-aspartate-glycine, written in single-letter code as AEDG. The four residues are joined by three peptide bonds, giving a linear backbone with no branching and no disulfide bridges. Its calculated molecular mass for the free form is approximately 390.3 daltons, a figure that rises when the compound is supplied as an acetate or trifluoroacetate salt. Because the chain is short, the molecule is defined entirely by its residue order rather than by any folded three-dimensional structure.

Notes from published material

Brazil, officially the Federative Republic of Brazil, is the largest country in South America. It is also the world's fifth-largest country by area and the seventh-largest by population, with over 214 million people. Brazil is a federation composed of 26 states and a Federal District, which hosts the capital, Brasília. Its most populous city is São Paulo, followed by Rio de Janeiro. Brazil has the largest Lusophone population in the world and is the only Portuguese-speaking country in the Americas, where it is the official language. Bounded by the Atlantic Ocean on the east, Brazil has a coastline of 7,491 kilometers (4,655 mi), among the longest in the world. Covering roughly half of South America's land area, it borders all other countries and territories on the continent except Ecuador and Chile. Brazil encompasses a wide range of tropical and subtropical landscapes, as well as wetlands, savannas, plateaus, and low mountains. It contains most of the Amazon basin, including the world's largest river system and most extensive virgin tropical forest. Brazil has diverse wildlife, a variety of ecological systems, and extensive natural resources spanning numerous protected habitats. It ranks first among 17 megadiverse countries, with its natural heritage being the subject of significant global interest, as environmental degradation (through processes such as deforestation) directly affect global issues such as climate change and biodiversity loss. Brazil was inhabited by various indigenous peoples prior to the landing of Portuguese explorer Pedro Álvares Cabral in 1500.

=== Early work in comedy and television === Morgan made his screen debut playing Hustle Man on the sitcom Martin. The character sold various items from the "hood", always greeting people with his signature "What's happ'n, chief?," and had a pet dog he dressed as a rapper. (Later, in the 2003 Chris Rock film Head of State, Morgan appeared as a man watching television, often questioning why they are not watching Martin.) Morgan was also a regular cast member on Uptown Comedy Club, a sketch-comedy show filmed in Harlem that aired for two seasons, from 1992 to 1994. Morgan joined the cast of the comedy series Saturday Night Live in 1996, and performed as a regular until 2003. Producer Lorne Michaels chose him over Stephen Colbert in the final round of auditions. Morgan's regular characters included the kindly but deluded vagrant Woodrow; outspoken apartment maintenance man Dominican Lou; lusty Astronaut Jones whose short skits ended with blunt sexual propositions towards beautiful extraterrestrial ladies; and Safari Planet host Brian Fellow who was enthusiastic but deeply ignorant about animals.

FS−SF → S=SF2 Decomposing to sulfur tetrafluoride and sulfur when heated to 180 °C: 2 S2F2 → SF4 + 3 S Hydrolysis: 2 S2F2 + 2 H2O → SO2 + 3 S + 4 HF Reacting with sulfuric acid at 80 °C: S2F2 + 3 H2SO4 → 5 SO2 + 2 HF + 2 H2O Reacting with sodium hydroxide: 2 S2F2 + 6 NaOH → Na2SO3 + 3 S + 4 NaF + 3 H2O Reacting with oxygen at high pressure, using nitrogen dioxide as a catalyst: 2 S2F2 + 5 O2 → SOF4 + 3 SO3

== Research == Neural drug delivery is the next step beyond the basic addition of growth factors to nerve guidance conduits. Drug delivery systems allow the rate of growth factor release to be regulated over time, which is critical for creating an environment more closely representative of in vivo development environments.

Sources: en.wikipedia.org

Further detail

== Computer System Validation == This requirement has naturally expanded to encompass computer systems used both in the development and production of, and as a part of pharmaceutical products, medical devices, food, blood establishments, tissue establishments, and clinical trials. In 1983 the FDA published a guide to the inspection of Computerized Systems in Pharmaceutical Processing, also known as the 'bluebook'. Recently both the American FDA and the UK Medicines and Healthcare products Regulatory Agency have added sections to the regulations specifically for the use of computer systems. In the UK, computer validation is covered in Annex 11 of the EU GMP regulations (EMEA 2011). The FDA introduced 21 CFR Part 11 for rules on the use of electronic records, electronic signatures (FDA 1997). The FDA regulation is harmonized with ISO 8402:1994, which treats "verification" and "validation" as separate and distinct terms. On the other hand, many software engineering journal articles and textbooks use the terms "verification" and "validation" interchangeably, or in some cases refer to software "verification, validation, and testing (VV&T)" as if it is a single concept, with no distinction among the three terms.

Freeman had four film releases in 1989. In the first, he starred as Sergeant Major John Rawlins in Glory, directed by Edward Zwick, about the 54th Massachusetts Infantry Regiment, the Union Army's second African-American regiment in the American Civil War. Writing for The Washington Post, Desson Thomson praised Freeman and co-star Denzel Washington for their "warming sense of fraternity". Glory was nominated for five Academy Awards and won three: Best Supporting Actor for Washington, Best Cinematography, and Best Sound. Next, Freeman starred in the comedy-drama Driving Miss Daisy, alongside Jessica Tandy and Dan Aykroyd. Based on Alfred Uhry's play of the same name in which Freeman had appeared previously, he reprises his role of Hoke Colburn, chauffeur for a Jewish widow. The film was a commercial success and grossed US$145 million worldwide. Film critics were mainly positive; Henry Sheehan from The Hollywood Reporter opined that Freeman and Tandy's performances complemented each other while retaining their "individual star-quality". The film was nominated for nine Academy Awards (and received four, Best Picture being one of them), including Best Actor for Freeman. His third release was the biographical drama Lean on Me, in which he portrays the principal of an under-performing and drug- and crime-ridden New Jersey high school. Jane Galbraith of Variety magazine thought Freeman's casting was "wonderful". Lastly in 1989, he starred in Walter Hill's Johnny Handsome, a crime drama in which he plays a New Orleans police officer.

The causative agent of yaws is Treponema pallidum pertenue, which is transmissible by direct physical contact between infected people. Yaws is not sexually transmitted, and occurs in tropical, humid environments of Africa, Pacific Islands, Asia and South America. Unlike syphilis, which displays vertical transmission, one strain of T. p. pertenue researched was not vertically transmissible in a guinea pig model, and yaws cannot be spread from mother to offspring. Yaws appears as skin lesions, usually papules, commonly on the lower extremities, but present in other areas such as the arms, trunk and hands. Three stages of yaws disease have been documented: primary yaws which presents as inflamed sores on the lower body, secondary yaws which presents as a variety of skin abnormalities along with bone inflammation, and tertiary yaws, also referred to as latent yaws, which occurs when T. p. pertenue is serologically detected in the host but no clinical signs are displayed until relapse, which often occurs years later. Yaws is treated with antibiotics such as azithromycin and benzathine penicillin-G.

Sources: en.wikipedia.org

Background from the literature

An important example of catch bonds is their role in leukocyte extravasation. During this process, leukocytes move through the circulatory system to sites of infection, and in doing so they 'roll' and bind to selectin molecules on the vessel wall. While able to float freely in the blood under normal circumstances, shear stress induced by inflammation causes leukocytes to attach to the endothelial vessel wall and begin rolling rather than floating downstream. This "shear-threshold phenomenon" was initially characterized in 1996 by Finger et al. who showed that leukocyte binding and rolling through L-selectin is only maintained when a critical shear-threshold is applied to the system. Multiple sources of evidence have shown that catch bonds are responsible for the tether and roll mechanism that allows this critical process to occur. Catch bonds allow increasing force to convert short-lived tethers into stronger, longer-lived binding interactions, thus decreasing the rolling velocity and increasing the regularity of rolling steps. However, this mechanism only works at an optimal force. As shear force increases past this force, bonds revert to slip bonds, creating an increase in velocity and irregularity of rolling.

=== Victims === On 17 September 2008, Health Minister Chen Zhu stated tainted milk formula had "sickened more than 6,200 children, and that more than 1,300 others, mostly newborns, remain hospitalized with 158 suffering from acute kidney failure". By 23 September, about 54,000 children were reported to be sick and four had died. An additional 10,000 cases were reported from the provinces by 27 September. A World Health Organization official said 82% of the children made ill were 2 years of age or below. The Hong Kong Centre for Food Safety said that 99 per cent of the victims were aged under 3 years. Ten Hong Kong children were diagnosed with kidney problems, at least four cases were detected in Macau, and six in Taiwan. Non-human casualties included a lion cub and two baby orangutans which had been fed Sanlu infant formula at Hangzhou Zoo. The government said on 8 October it would no longer issue updated figures "because it is not an infectious disease, so it's not absolutely necessary for us to announce it to the public". Reuters compiled figures reported by local media across the country, and said the toll stood at nearly 94,000 at the end of September, excluding municipalities. Notably, 13,459 children had been affected in Gansu, Reuters quoted Xinhua saying Henan had reported over 30,000 cases, and Hebei also had nearly 16,000 cases. In late October, the government announced health officials had surveyed 300,000 Beijing families with children less than 3 years old.

=== Pediatrics === In a meta analysis of 17 studies, PCT had a sensitivity of 85% and a specificity of 54% in diagnosing sepsis in neonates and children. The PCT cut off used was between 2-2.5 ng/mL. In children presenting with fever without an apparent source, a PCT level of .5 ng/mL had a sensitivity of 82% and specificity of 86%. At a 5 ng/mL value, the sensitivity and specificity were 61% and 94%. PCT can help the clinical decision making while identifying invasive bacterial infection in children with unexplained fever. PCT levels correlate with the degree of illness in pediatric patients with sepsis or urinary tract infections making it effective as a prognostic lab value in these patients.

The movement for a single-island region started in the 1980s when officials of both provinces proposed a one-island, one-region unit. Negros Occidental and Negros Oriental are the only provinces in the Philippines situated in the same island but belonging to two different administrative regions with regional offices located in neighboring Panay and Cebu. The movement to unite the two provinces in Negros island was sustained in the 1990s and 2010s. The campaign for the creation of a region in Negros had gains when President Benigno Aquino III directed the Department of the Interior and Local Government (DILG) to study the establishment of a new region. with the government agency later endorsing the move. NEDA affirmed by saying that its studies show that the proposed region is economically viable. On May 29, 2015, President Aquino signed Executive Order 183, which created the Negros Island Region. It separated Negros Occidental and its capital Bacolod from Western Visayas (Region VI) and Negros Oriental from Central Visayas (Region VII) to form the island region, which made the total number of regions of the Philippines into 18.

Sources: en.wikipedia.org

Frequently asked questions

Who developed epitalon?

Vladimir Khavinson and colleagues at research institutes in Saint Petersburg developed and studied the peptide. Their program examined short peptides as regulators of aging and neuroendocrine function. Epitalon was one of several compounds produced by that group.

Does epitalon lengthen telomeres in humans?

That question is not settled. Cell culture studies have reported increased telomerase activity after treatment, but comparable evidence from controlled human trials is lacking. Any claim about telomere lengthening in people should be treated as unproven.

Why is epitalon not an approved medicine?

It has not completed the large, controlled trials required for drug approval in major jurisdictions. Most human reports involve small samples and limited follow-up. As a result, it is sold as a research chemical rather than a licensed pharmaceutical product.

What is epitalon made of?

Epitalon is a synthetic tetrapeptide composed of four amino acids: alanine, glutamate, aspartate, and glycine. It is written as Ala-Glu-Asp-Gly. The free peptide has a molecular weight of about 390 daltons and is normally supplied as a lyophilized powder.

Network